| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Alemtuzumab (Lemtrada) | 2025-12-15 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Ublituximab-xiiy (Briumvi) | 2025-12-15 |
| BCBS Highmark Penn Medicare Advantage | Ocrelizumab (Ocrevus) and Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo) | 2025-12-15 |
| BCBS Highmark NY and West NY | Ostomy Supplies | 2025-12-15 |
| BCBS Highmark NY and West NY | Ublituximab-xiiy (Briumvi) | 2025-12-15 |
| BCBS Highmark NY and West NY | Alemtuzumab (Lemtrada) | 2025-12-15 |
| BCBS Highmark Delaware | Ostomy Supplies | 2025-12-15 |
| BCBS Highmark Delaware | Alemtuzumab (Lemtrada) | 2025-12-15 |
| BCBS Highmark Delaware | Ublituximab-xiiy (Briumvi) | 2025-12-15 |
| BCBS Highmark West Virginia | Ublituximab-xiiy (Briumvi) | 2025-12-15 |